These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15381036)

  • 1. Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide.
    Marano RJ; Wimmer N; Kearns PS; Thomas BG; Toth I; Brankov M; Rakoczy PE
    Exp Eye Res; 2004 Oct; 79(4):525-35. PubMed ID: 15381036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
    Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
    Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A2 promotes choroidal neovascularization by increasing vascular endothelial growth factor expression in a rat model of argon laser coagulation-induced choroidal neovascularization.
    Zhao SH; Pan DY; Zhang Y; Wu JH; Liu X; Xu Y
    Chin Med J (Engl); 2010 Mar; 123(6):713-21. PubMed ID: 20368092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization.
    Zhou XY; Liao Q; Pu YM; Tang YQ; Gong X; Li J; Xu Y; Wang ZG
    Chin Med J (Engl); 2009 Nov; 122(22):2711-7. PubMed ID: 19951601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
    Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of vascular endothelial growth factor and its receptor in experimental choroidal neovascularization in rat].
    Zhao SH; He SZ; Shi XH
    Zhonghua Yan Ke Za Zhi; 2004 Aug; 40(8):522-7. PubMed ID: 15454039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.
    Cashman SM; Bowman L; Christofferson J; Kumar-Singh R
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3496-504. PubMed ID: 16877421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
    Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity.
    Marano RJ; Toth I; Wimmer N; Brankov M; Rakoczy PE
    Gene Ther; 2005 Nov; 12(21):1544-50. PubMed ID: 16034458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pitavastatin on experimental choroidal neovascularization in rats.
    Sagara N; Kawaji T; Takano A; Inomata Y; Inatani M; Fukushima M; Tanihara H
    Exp Eye Res; 2007 Jun; 84(6):1074-80. PubMed ID: 17418120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of choroidal neovascularization in lectin-like oxidized low-density lipoprotein receptor type 1-deficient mice.
    Inomata Y; Fukushima M; Hara R; Takahashi E; Honjo M; Koga T; Kawaji T; Satoh H; Takeya M; Sawamura T; Tanihara H
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3970-6. PubMed ID: 19182261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
    Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the temporal expression of regulatory growth factors during choroidal neovascular development.
    Hu W; Criswell MH; Fong SL; Temm CJ; Rajashekhar G; Cornell TL; Clauss MA
    Exp Eye Res; 2009 Jan; 88(1):79-91. PubMed ID: 19013152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA/dendrimer complexes mediate gene transfer into murine cardiac transplants ex vivo.
    Wang Y; Boros P; Liu J; Qin L; Bai Y; Bielinska AU; Kukowska-Latallo JF; Baker JR; Bromberg JS
    Mol Ther; 2000 Dec; 2(6):602-8. PubMed ID: 11124061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
    Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
    J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils promote experimental choroidal neovascularization.
    Zhou J; Pham L; Zhang N; He S; Gamulescu MA; Spee C; Ryan SJ; Hinton DR
    Mol Vis; 2005 Jun; 11():414-24. PubMed ID: 15988410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells.
    Aukunuru JV; Ayalasomayajula SP; Kompella UB
    J Pharm Pharmacol; 2003 Sep; 55(9):1199-206. PubMed ID: 14604462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo use of oligonucleotides to inhibit choroidal neovascularisation in the eye.
    Garrett KL; Shen WY; Rakoczy PE
    J Gene Med; 2001; 3(4):373-83. PubMed ID: 11529667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.